We will use cookies and other information to optimize your experience. By continuing to browse, you consent to our use. For details, please read
Privacy Policy
×
RuenHuei Biopharmaceuticals Inc.
Language
English
繁體中文
ABOUT US
Company Overview
Juine-Ruey (JR) Chen Ph.D
Management Team
NEWS
Media
Interview
PIPELINE
Overview
Flu Vaccine Platform
C34 Adjuvant Formulation
PRODUCTS
CONTACT
Home
NEWS
Media
18
2019.01
Development of monoglycosyalated HA (HAmg) as a universal flu vaccine.
English
繁體中文
Language
English
繁體中文
ABOUT US
Company Overview
Juine-Ruey (JR) Chen Ph.D
Management Team
NEWS
Media
Interview
PIPELINE
Overview
Flu Vaccine Platform
C34 Adjuvant Formulation
PRODUCTS
CONTACT
